Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May 26;15(11):2478.
doi: 10.3390/nu15112478.

The Interplay between Metabolic Syndrome and Religious Fasting in Postmenopausal Women

Affiliations

The Interplay between Metabolic Syndrome and Religious Fasting in Postmenopausal Women

Anna Kokkinopoulou et al. Nutrients. .

Abstract

Religious fasting that involves abstinence from specific food(s) is part of many religions worldwide and has been gaining attention by the research community during the last years. The study aimed to investigate whether the periodic Christian Orthodox fasting mitigates the changes in body composition, dietary intake, and metabolic syndrome (MetS) in postmenopausal women. One hundred and thirty-four postmenopausal women aged 57.3 ± 6.7 years participated in this study. The Christian Orthodox fasting was followed by 68 postmenopausal women since their childhood, whereas 66 postmenopausal women were non-fasters. Data collection involved anthropometric, biochemical, clinical, and dietary information. Postmenopausal women who fasted according to Christian Orthodox Church recommendations had significantly higher mean fat free mass (45 vs. 44 kg, p = 0.002), hip circumference (104 vs. 99 cm, p = 0.001), and diastolic blood pressure (79 vs. 82 mmHg, p = 0.024). No other differences were found with regards to anthropometric data. Fasters also consumed significantly less fat (78 vs. 91 g, p = 0.006), as well as saturated (19 vs. 23 g, p = 0.015), monounsaturated (41 vs. 47 g, p = 0.018), and polyunsaturated fat (8.5 vs. 10 g, p = 0.023), trans fatty acids (0.5 vs. 2.3 g, p = 0.035), and cholesterol (132 vs. 176 g, p = 0.011). In terms of MetS features, non-fasters had more frequently elevated fasting blood glucose (11.8 vs. 24.2%, p = 0.039) and elevated blood pressure (13.2 vs. 36.4%, p = 0.041) compared with fasters. MetS was more common in non-fasters versus fasters with a marginal level of significance (30.3 vs. 23.5%, p = 0.052). Postmenopausal women who follow the Christian Orthodox fasting regime had lower fat intake, and no other difference in nutrient intake, compared with non-fasters. The latter were more likely to have MetS and some of its components. Overall, periodic abstinence from meat, dairy products, and eggs might play a protective role in postmenopausal women with regard to MetS.

Keywords: Christian Orthodox fasting; blood lipids; metabolic syndrome; nutrient intake; postmenopausal women; religious fasting.

PubMed Disclaimer

Conflict of interest statement

Emmanouil Dermitzakis is a GSK employee. This work was performed before his appointment at GSK.

Similar articles

Cited by

References

    1. Litwin M., Kułaga Z. Obesity, metabolic syndrome, and primary hypertension. Pediatr. Nephrol. Berl. Ger. 2021;36:825–837. doi: 10.1007/s00467-020-04579-3. - DOI - PMC - PubMed
    1. Shalitin S., Giannini C. Obesity, Metabolic Syndrome, and Nutrition. World Rev. Nutr. Diet. 2023;126:47–69. doi: 10.1159/000527938. - DOI - PubMed
    1. Kozakowski J., Gietka-Czernel M., Leszczyńska D., Majos A. Obesity in menopause–our negligence or an unfortunate inevitability? Prz. Menopauzalny Menopause Rev. 2017;16:61–65. doi: 10.5114/pm.2017.68594. - DOI - PMC - PubMed
    1. Juppi H., Sipilä S., Fachada V., Hyvärinen M., Cronin N., Aukee P., Karppinen J.E., Selänne H., Kujala U.M., Kovanen V., et al. Total and regional body adiposity increases during menopause-evidence from a follow-up study. Aging Cell. 2022;21:e13621. doi: 10.1111/acel.13621. - DOI - PMC - PubMed
    1. Nappi R.E., Chedraui P., Lambrinoudaki I., Simoncini T. Menopause: A cardiometabolic transition. Lancet Diabetes Endocrinol. 2022;10:442–456. doi: 10.1016/S2213-8587(22)00076-6. - DOI - PubMed